Is compounded tirzepatide 'generic Zepbound'?

No. There is no generic tirzepatide. A compounded preparation is made by a pharmacy from the active ingredient and is not an approved product of any kind.

Can I switch between them?

That is a clinical decision. The two are dosed differently in practice (fixed pen or vial strengths versus a volume drawn from a multi-dose vial), so a switch involves the prescriber, not just the price.

Published August 27, 2026 · updated August 27, 2026 · medically reviewed by Dr. S. Shuwart, MD on August 27, 2026

Medically reviewed · August 27, 2026

Zepbound vs compounded tirzepatide: cost, formulation and evidence

How the FDA-approved product compares with compounded tirzepatide on what you receive, what the evidence covers, how dosing works, and how the two are priced through telehealth.

What Zepbound is

Zepbound is Eli Lilly’s tirzepatide product approved for chronic weight management in adults with obesity, or overweight with a weight-related condition, and for moderate-to-severe obstructive sleep apnoea in adults with obesity. It is supplied as single-dose pens and as single-dose vials in fixed strengths from 2.5 mg to 15 mg. The label contains the dosing schedule, the trial results (the SURMOUNT programme) and the warnings, and every unit is manufactured under the manufacturer’s FDA-inspected quality system.

What compounded tirzepatide is

A preparation made by a 503A pharmacy or a 503B outsourcing facility from tirzepatide active ingredient, usually as a multi-dose vial at a concentration the pharmacy chooses, sometimes with an added ingredient such as vitamin B6, B12, glycine or niacinamide. It is not FDA-approved, has no label of its own, and was not tested in the SURMOUNT trials.

Where they differ

Dose delivery. Zepbound pens deliver a fixed dose; vials are drawn with a syringe at the labelled strength. Compounded vials are drawn by volume, so the dose depends on the concentration on the pharmacy label and on measuring correctly. That is why compounded plans on this site show the concentration and total milligrams per vial where the provider publishes them, and why price bands are usually tied to total milligrams.

Evidence. The approved product carries phase 3 evidence and a cardiovascular and sleep-apnoea programme; on this site it is evidence grade A. Compounded injectable tirzepatide is grade C: the molecule and route are proven in the approved product, but the compounded preparation itself has not been tested. Additive-containing versions do not gain evidence from the additive.

Regulation. Compounding copies of an approved drug is permitted only in defined circumstances. The legal status page describes what changed when the shortage ended and on what basis providers continue.

Price structure. Zepbound through telehealth is usually a manufacturer direct-to-patient cash price passed through with a plan or visit fee on top, or an insured prescription with a copay; this site records the medication price and the fee separately when a provider publishes them. Compounded plans are priced by the provider and typically rise in bands as the weekly dose rises. Both appear in the tirzepatide pricing list with their verification dates; the calculator puts them side by side over twelve months using your own fee inputs.

Questions that decide it

Whether insurance or a savings program makes Zepbound affordable; whether you want the evidence and quality assurance of an approved product; and, if considering compounded, whether the provider names the pharmacy, states the form of the active ingredient and the concentration, and publishes the price at 10 mg and 15 mg. The questions to ask cover these.

Questions this page answers

Is compounded tirzepatide 'generic Zepbound'?: No. There is no generic tirzepatide. A compounded preparation is made by a pharmacy from the active ingredient and is not an approved product of any kind.
Can I switch between them?: That is a clinical decision. The two are dosed differently in practice (fixed pen or vial strengths versus a volume drawn from a multi-dose vial), so a switch involves the prescriber, not just the price.

Sources

Zepbound (tirzepatide) prescribing information (label)
FDA: Human drug compounding (regulator)
Verified tirzepatide plan prices (provider)

Educational information, not medical advice. Decisions about GLP-1 medication belong with you and a licensed clinician who knows your history. Compounded medications are not FDA-approved. Report an error.